Announcements Trials
Browse Landscape

Phase

Phase 2/3 1Phase 1/2 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Prostatic Neoplasms 683Carcinoma, Renal Cell 225Urinary Bladder Neoplasms 195Carcinoma, Transitional Cell 111Breast Neoplasms 96Kidney Neoplasms 89Carcinoma, Non-Small-Cell Lung 82Neoplasms 81Melanoma 78Ovarian Neoplasms 77Colorectal Neoplasms 68Neoplasm Metastasis 66Non-Muscle Invasive Bladder Neoplasms 56Lung Neoplasms 53Pancreatic Neoplasms 46Sarcoma 45Stomach Neoplasms 42Endometrial Neoplasms 41Uterine Cervical Neoplasms 39Wilms Tumor 33Adenocarcinoma 33Esophageal Neoplasms 31Carcinoma, Hepatocellular 31Squamous Cell Carcinoma of Head and Neck 30Triple Negative Breast Neoplasms 29Head and Neck Neoplasms 27Testicular Neoplasms 24Metastatic Castration-resistant Prostate Cancer 24Neuroblastoma 23Colonic Neoplasms 23

Interventions

orellanine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Kidney Failure, Chronic × Genitourinary × 90 days × Clear all
NCT02984124 2026-05-29

CHART

University of Vermont

Phase 2/3 Completed
182 enrolled
Genitourinary

Kidney Failure, Chronic

NCT05287945 2026-05-22

Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinoma

Oncorena AB

Phase 1/2 Recruiting
75 enrolled
Genitourinary

Carcinoma, Renal Cell, Kidney Failure, Chronic, Kidney Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡